Cargando…
Lymphoma complicating rheumatoid arthritis: results from a French case–control study
OBJECTIVES: To study the characteristics of B-cell non-Hodgkin’s lymphoma (NHL) or Hodgkin lymphoma complicating rheumatoid arthritis (RA) and to identify RA-related factors associated with their occurrence. METHODS: A multicentre case–control study was performed in France. Cases were patients with...
Autores principales: | Kedra, Joanna, Seror, Raphaele, Dieudé, Philippe, Constantin, Arnaud, Toussirot, Eric, Kfoury, Elias, Masson, Charles, Cornec, Divi, Dubost, Jean Jacques, Marguerie, Laurent, Ottaviani, Sebastien, Grados, Franck, Belkhir, Rakiba, Fain, Olivier, Goupille, Philippe, Sordet, Christelle, Fautrel, Bruno, Philippe, Peggy, Piperno, Muriel, Combe, Bernard, Lambotte, Olivier, Richez, Christophe, Sellam, Jérémie, Sené, Thomas, Denis, Guillaume, Lequerre, Thierry, Lazure, Thierry, Mariette, Xavier, Nocturne, Gaetane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413949/ https://www.ncbi.nlm.nih.gov/pubmed/34470830 http://dx.doi.org/10.1136/rmdopen-2021-001698 |
Ejemplares similares
-
Low numbers of blood and salivary natural killer cells are associated with a better response to belimumab in primary Sjögren’s syndrome: results of the BELISS study
por: Seror, Raphaèle, et al.
Publicado: (2015) -
Large granular lymphocyte expansions in primary Sjögren’s syndrome: characteristics and outcomes
por: Baber, Alistair, et al.
Publicado: (2019) -
Characteristics of Sjögren’s syndrome associated with rheumatoid arthritis
por: Hassold, Nolan, et al.
Publicado: (2022) -
Very low rate of humoral response after a third COVID-19 vaccine dose in patients with autoimmune diseases treated with rituximab and non-responders to two doses
por: Bitoun, Samuel, et al.
Publicado: (2022) -
Efficacy of daratumumab in refractory primary Sjögren disease
por: Nocturne, Gaetane, et al.
Publicado: (2023)